Paul Hammerness
Overview
Explore the profile of Paul Hammerness including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Medina A, Hammerness P, Ihyembe D, Plummer S, Diekroger E, Fogler J
J Dev Behav Pediatr
. 2024 Jun;
45(3):e271-e273.
PMID: 38905008
DL is an 8-year-old Mexican boy with a posterior atrial septal defect and partial anomalous pulmonary venous return of the right lower pulmonary vein with resultant right heart dilation with...
2.
Albanna A, Soubra K, Alhashmi D, Alloub Z, AlOlama F, Hammerness P, et al.
East Mediterr Health J
. 2023 Sep;
29(9):742-748.
PMID: 37776136
Background: Attention deficit hyperactivity disorder is a common neurodevelopmental disorder. Accessing services for this disorder is a worldwide challenge and requires innovative interventions. Aims: We aimed to investigate the effectiveness...
3.
Hammerness P, Berger A, Angelini M, Wilens T
Child Adolesc Psychiatr Clin N Am
. 2022 Jun;
31(3):437-448.
PMID: 35697394
The cardiovascular (CV) impact of stimulants has been examined for decades, with investigations ranging from small sample targeted studies of heart rate (HR) and blood pressure (BP), to large scale...
4.
Partain P, White J, Hammerness P
Curr Opin Pediatr
. 2018 Dec;
31(1):166-174.
PMID: 30531224
Purpose Of Review: To provide an up-to-date clinical review of U.S. Food and Drug Administration (FDA)-approved stimulant medications for attention-deficit/hyperactivity disorder (ADHD), including a framework for individualized treatment by primary...
5.
Hauptman A, Acar D, Hammerness P, Fogler J, Stafford D
Harv Rev Psychiatry
. 2018 Nov;
26(6):384-391.
PMID: 30407237
No abstract available.
6.
Sprich S, Safren S, Finkelstein D, Remmert J, Hammerness P
J Child Psychol Psychiatry
. 2016 Mar;
57(11):1218-1226.
PMID: 26990084
Objective: To test cognitive behavioral therapy (CBT) for persistent attention-deficit hyperactivity disorder (ADHD) symptoms in a sample of medication-treated adolescents. Methods: Forty-six adolescents (ages 14-18), with clinically significant ADHD symptoms...
7.
Munshi K, Alexander M, Hammerness P
J Am Acad Child Adolesc Psychiatry
. 2014 Dec;
54(1):9-10.
PMID: 25524785
No abstract available.
8.
Ulbricht C, Basch E, Cheung L, Goldberg H, Hammerness P, Isaac R, et al.
J Diet Suppl
. 2014 Jan;
11(1):80-120.
PMID: 24409980
An evidence-based systematic review of elderberry and elderflower (Sambucus nigra) by the Natural Standard Research Collaboration consolidates the safety and efficacy data available in the scientific literature using a validated,...
9.
Hammerness P, Fried R, Petty C, Meller B, Biederman J
Child Neuropsychol
. 2013 May;
20(3):319-27.
PMID: 23639146
Aim: To psychometrically assess cognitive domains in adolescents with ADHD during long-term open treatment with robust dosing of extended-release methylphenidate (OROS MPH). Methods: Data were derived from a prospective clinical...
10.
Biederman J, Pettye C, Hammerness P, Woodworth K, Faraon S
Can J Psychiatry
. 2013 Mar;
58(3):177-83.
PMID: 23461889
Objective: To use familial risk analysis to examine the association between attention-deficit hyperactivity disorder (ADHD) and nicotine dependence (ND). Method: Subjects were children with (n = 257) and without (n...